UB Paderborn / Katalog / Suche / in CDI

Impact of daratumumab/bortezomib/thalidomide and dexamethasone induction therapy on chemo-free stem cell mobilization in transplant eligible newly diagnosed multiple myeloma: a multicentre real-world experience

Haematologica (Roma), 2024-10

2024

Volltextzugriff (PDF)

The place of allogeneic stem cell transplantation in aggressive B-cell non-Hodgkin lymphoma in the era of CAR-T-cell therapy

Frontiers in medicine, 2022-12, Vol.9, p.1072192-1072192

2022

Volltextzugriff (PDF)

Regulatory Cytokine Gene Polymorphisms and Risk of Colorectal Carcinoma

Annals of the New York Academy of Sciences, 2006-11, Vol.1089 (1), p.98-103

2006

Volltextzugriff (PDF)

Cytokine Gene Polymorphisms and Breast Cancer Susceptibility

Annals of the New York Academy of Sciences, 2006-11, Vol.1089 (1), p.104-109

2006

Volltextzugriff (PDF)

Benign form of myasthenia gravis after nivolumab treatment

Muscle & nerve, 2016-09, Vol.54 (3), p.507-509

2016

Volltextzugriff (PDF)

Prognostic impact of depth of response (DpR) and early tumour shrinkage (ETS) in patients (pts) with BRAF V600E mutated (mut) metastatic colorectal cancer (mCRC) receiving targeted therapy (TT) as second-line treatment

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.3568-3568

2023

Volltextzugriff (PDF)

P-360 Impact of Daratumumab/Bortezomib/Thalidomide/Dexamethasone (DVTD) Induction Therapy on Chemo-Free Stem Cell Mobilization in Newly Diagnosed Multiple Myeloma Patients: A Real Life Experience

Clinical lymphoma, myeloma and leukemia, 2024-09, Vol.24, p.S241-S241

2024

Volltextzugriff (PDF)

Ceritinib in the treatment of an adult patient with advanced neuroblastoma positive to the somatic activating mutation of ALK F1174L.

Recenti progressi in medicina, 2020-12, Vol.111 (12), p.58e

2020

Volltextzugriff (PDF)

Phase II, noncomparative, open label, multicenter, study of osimertinib, in patients with locally advanced or metastatic EGFR mutated, T790M undetectable or unknown non-small cell lung cancer (Stage IIIB-IV) after no immediate prior EGFR TKI (OSIRIS study)

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e21116-e21116

2021

Volltextzugriff (PDF)

P1.03-015 Assessment of Response of FDG-PET Using Total Lesion Glycolysis (TLG) in NSCLC Patients Treated with Nivolumab: Results of a Pilot Study

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S551

2017

Volltextzugriff (PDF)

P3.02c-090 The Role of ERCC-1 Polymorphisms as Predictive Biomarker of Response to Nivolumab in Advanced NSCLC: Topic: IT Biomarkers

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S1333-S1333

2017

Volltextzugriff (PDF)

P3.02c-090 The Role of ERCC-1 Polymorphisms as Predictive Biomarker of Response to Nivolumab in Advanced NSCLC

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S1333

2017

Volltextzugriff (PDF)

P1.03-015 Assessment of Response of FDG-PET Using Total Lesion Glycolysis (TLG) in NSCLC Patients Treated with Nivolumab: Results of a Pilot Study: Topic: Radiology

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S551-S551

2017

Volltextzugriff (PDF)

A phase II, noncomparative, open label, multicentre, study of AZD9291 in patients with locally advanced or metastatic EGFR mutated “T790M undetectable or unknown” non-small cell lung cancer (stage IIIB-IV) after no immediate prior EGFR TKI (OSIRIS study)

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.TPS9107-TPS9107

2017

Volltextzugriff (PDF)

Circulating miRNA signatures: a new challenge in castration-resistant prostate cancer

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e16100-e16100

2015

Volltextzugriff (PDF)

Impact of erlotinib activity on overall survival in non small cell lung cancer patients: Is the post progression survival a new paradigm?

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.e19086-e19086

2013

Volltextzugriff (PDF)

Gender influence on professional satisfaction and gender issue perception among young oncologists. A survey of the Young Oncologists Working Group of the Italian Association of Medical Oncology (AIOM)

ESMO open, 2018, Vol.3 (6), p.e000389-e000389, Article e000389

2018

Volltextzugriff (PDF)

Treatment and outcome(s) of a large cohort of Italian patients (pts) with poor-risk metastatic renal cell carcinoma (prRCC)

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.e15568-e15568

2014

Volltextzugriff (PDF)

Emerging targeted therapies for castration-resistant prostate cancer

Frontiers in endocrinology (Lausanne), 2012, Vol.3, p.73-73

2012

Volltextzugriff (PDF)

The role of platelet gel in osteoarticular injuries of young and old patients

Immunity & ageing, 2014-12, Vol.11 (1), p.21-21, Article 21

2014

Volltextzugriff (PDF)

LAS REPRESENTACIONES DE DIRECTIVOS DE ISFD ACERCA DE LA PROBLEMÁTICA DE LA INCORPORACIÓN DE TIC EN LA FORMACIÓN DOCENTE

Revista question, 2010-03, Vol.1 (25)

2010

Volltextzugriff (PDF)

Delusion of parasitosis: report of twelve cases

Vertex (Buenos Aires, Argentina), 2008-05, Vol.19 (79), p.99

2008

Volltextzugriff (PDF)

Bladder Cancer

Practical Medical Oncology Textbook, 2021, p.775-790

2021

Volltextzugriff (PDF)

Paniculitis histiocítica citofágica con remisión espontánea

Dermatología Argentina, 2020-06, Vol.26 (2), p.73-75

2020

Volltextzugriff (PDF)

An efficient barrier toward vanadium crossover in redox flow batteries: The bilayer [Nafion/(WO3)x] hybrid inorganic-organic membrane

Electrochimica acta, 2021-05, Vol.378, p.138133, Article 138133

2021

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Impact of daratumumab/bortezomib/thalidomide and dexamethasone induction therapy on chemo-free stem cell mobilization in transplant eligible newly diagnosed multiple myeloma: a multicentre real-world experience

The place of allogeneic stem cell transplantation in aggressive B-cell non-Hodgkin lymphoma in the era of CAR-T-cell therapy

Regulatory Cytokine Gene Polymorphisms and Risk of Colorectal Carcinoma

Cytokine Gene Polymorphisms and Breast Cancer Susceptibility

Benign form of myasthenia gravis after nivolumab treatment

Prognostic impact of depth of response (DpR) and early tumour shrinkage (ETS) in patients (pts) with BRAF V600E mutated (mut) metastatic colorectal cancer (mCRC) receiving targeted therapy (TT) as second-line treatment

P-360 Impact of Daratumumab/Bortezomib/Thalidomide/Dexamethasone (DVTD) Induction Therapy on Chemo-Free Stem Cell Mobilization in Newly Diagnosed Multiple Myeloma Patients: A Real Life Experience

Ceritinib in the treatment of an adult patient with advanced neuroblastoma positive to the somatic activating mutation of ALK F1174L.

Phase II, noncomparative, open label, multicenter, study of osimertinib, in patients with locally advanced or metastatic EGFR mutated, T790M undetectable or unknown non-small cell lung cancer (Stage IIIB-IV) after no immediate prior EGFR TKI (OSIRIS study)

P1.03-015 Assessment of Response of FDG-PET Using Total Lesion Glycolysis (TLG) in NSCLC Patients Treated with Nivolumab: Results of a Pilot Study

P3.02c-090 The Role of ERCC-1 Polymorphisms as Predictive Biomarker of Response to Nivolumab in Advanced NSCLC: Topic: IT Biomarkers

P3.02c-090 The Role of ERCC-1 Polymorphisms as Predictive Biomarker of Response to Nivolumab in Advanced NSCLC

P1.03-015 Assessment of Response of FDG-PET Using Total Lesion Glycolysis (TLG) in NSCLC Patients Treated with Nivolumab: Results of a Pilot Study: Topic: Radiology

A phase II, noncomparative, open label, multicentre, study of AZD9291 in patients with locally advanced or metastatic EGFR mutated “T790M undetectable or unknown” non-small cell lung cancer (stage IIIB-IV) after no immediate prior EGFR TKI (OSIRIS study)

Circulating miRNA signatures: a new challenge in castration-resistant prostate cancer

Impact of erlotinib activity on overall survival in non small cell lung cancer patients: Is the post progression survival a new paradigm?

Gender influence on professional satisfaction and gender issue perception among young oncologists. A survey of the Young Oncologists Working Group of the Italian Association of Medical Oncology (AIOM)

Treatment and outcome(s) of a large cohort of Italian patients (pts) with poor-risk metastatic renal cell carcinoma (prRCC)

Emerging targeted therapies for castration-resistant prostate cancer

The role of platelet gel in osteoarticular injuries of young and old patients

LAS REPRESENTACIONES DE DIRECTIVOS DE ISFD ACERCA DE LA PROBLEMÁTICA DE LA INCORPORACIÓN DE TIC EN LA FORMACIÓN DOCENTE

Delusion of parasitosis: report of twelve cases

Bladder Cancer

Paniculitis histiocítica citofágica con remisión espontánea

An efficient barrier toward vanadium crossover in redox flow batteries: The bilayer [Nafion/(WO3)x] hybrid inorganic-organic membrane

Suchergebnisse filtern